Page last updated: 2024-10-31

ml 7 and Colitis

ml 7 has been researched along with Colitis in 2 studies

ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).

Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conlin, VS1
Wu, X1
Nguyen, C1
Dai, C1
Vallance, BA1
Buchan, AM1
Boyer, L1
Jacobson, K1
Liu, X1
Xu, J1
Mei, Q1
Han, L1
Huang, J1

Other Studies

2 other studies available for ml 7 and Colitis

ArticleYear
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 297, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Azepines; Bacterial Adhesion; Bacterial Translocation; Caco-2 Cel

2009
Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.
    Digestive diseases and sciences, 2013, Volume: 58, Issue:1

    Topics: Animals; Azepines; Colitis; Cytokines; Dextran Sulfate; Enzyme Inhibitors; Gene Expression Regulatio

2013